We are live on
!
Find out more
GAA
Green Alpha Advisors Portfolio holdings
AUM
$148M
Turnover
14.17%
1-Year Est. Return
98.22%
This Fund
S&P 500
This Quarter
Est. Return
+10.2%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$45.8M
(+45%)
Cap. Flow
+$35.4M
Cap. Flow
% of AUM
24.09%
Top 10 Holdings %
Top 10 Hldgs %
15.71%
Holding
140
New
29
Increased
66
Reduced
32
Closed
13
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hudson Pacific Properties
HPP
|
+$1.72M |
| 2 |
ASML
ASML
|
+$1.43M |
| 3 |
Kilroy Realty
KRC
|
+$1.4M |
| 4 |
Vornado Realty Trust
VNO
|
+$1.3M |
| 5 |
Steelcase
SCS
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95M |
| 2 |
Daqo New Energy
DQ
|
+$1.74M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.4M |
| 4 |
NVIDIA
NVDA
|
+$1.04M |
| 5 |
Moderna
MRNA
|
+$893K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 46.13% |
| 2 | Healthcare | 14.79% |
| 3 | Real Estate | 11.73% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Industrials | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Twist Bioscience
TWST
$9.58B
| $728K | 0.5% |
+5,460
| New | +$635K |
2021 Q2
0 quarters
|
|
102
Xylem
XYL
$24.1B
| $711K | 0.48% |
5,923
-581
| -9% | -$66.3K |
2020 Q4
2 quarters
|
|
103
Pacific Biosciences
PACB
$609M
| $709K | 0.48% |
+20,279
| New | +$590K |
2021 Q2
0 quarters
|
|
104
VEON
VEON
$5.7B
| $696K | 0.47% |
15,208
+10,569
| +228% | +$466K |
2020 Q4
2 quarters
|
|
105
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $677K | 0.46% |
+24,575
| New | +$483K |
2021 Q2
0 quarters
|
|
106
QuantumScape Corp
QS
$2.62B
| $644K | 0.44% |
+22,022
| New | +$712K |
2021 Q2
0 quarters
|
|
107
Advanced Drainage Systems
WMS
$9.69B
| $631K | 0.43% |
+5,417
| New | +$601K |
2021 Q2
0 quarters
|
|
108
Arcturus Therapeutics
ARCT
$320M
| $613K | 0.42% |
+18,122
| New | +$613K |
2021 Q2
0 quarters
|
|
109
Hain Celestial
HAIN
$25.7M
| $603K | 0.41% |
15,024
+7,574
| +102% | +$313K |
2020 Q4
2 quarters
|
|
110
Ormat Technologies
ORA
$5.51B
| $597K | 0.41% |
8,582
+3,580
| +72% | +$255K |
2020 Q4
2 quarters
|
|
111
Personalis
PSNL
$1.7B
| $595K | 0.41% |
+23,537
| New | +$539K |
2021 Q2
0 quarters
|
|
112
Inovio Pharmaceuticals
INO
$108M
| $580K | 0.39% |
+5,214
| New | +$501K |
2021 Q2
0 quarters
|
|
113
DELISTED
Primo Water Corporation
PRMW
| $578K | 0.39% |
+34,558
| New | +$584K |
2021 Q2
0 quarters
|
|
|
SGEN
114
DELISTED
Seagen Inc. Common Stock
SGEN
| $565K | 0.38% |
3,576
+505
| +16% | +$75K |
2020 Q4
2 quarters
|
|
115
DELISTED
Exact Sciences
EXAS
| $541K | 0.37% |
4,356
+1,659
| +62% | +$198K |
2021 Q1
1 quarter
|
|
116
Array Technologies
ARRY
$550M
| $522K | 0.36% |
+33,475
| New | +$706K |
2021 Q2
0 quarters
|
|
117
Where Food Comes From
WFCF
$70M
| $510K | 0.35% |
+32,952
| New | +$488K |
2021 Q2
0 quarters
|
|
118
Philips
PHG
$24.9B
| $503K | 0.34% |
12,262
+3,680
| +43% | +$170K |
2020 Q4
2 quarters
|
|
|
NSTG
119
DELISTED
NanoString Technologies, Inc.
NSTG
| $496K | 0.34% |
+7,648
| New | +$486K |
2021 Q2
0 quarters
|
|
120
Vertex Pharmaceuticals
VRTX
$129B
| $484K | 0.33% |
2,398
+479
| +25% | +$100K |
2021 Q1
1 quarter
|
|
121
Protolabs
PRLB
$2.09B
| $477K | 0.32% |
+5,196
| New | +$512K |
2021 Q2
0 quarters
|
|
122
DELISTED
CureVac
CVAC
| $334K | 0.23% |
+4,545
| New | +$454K |
2021 Q2
0 quarters
|
|
123
DELISTED
bluebird bio
BLUE
| $292K | 0.2% |
706
+137
| +24% | +$54.3K |
2021 Q1
1 quarter
|
|
|
ATHX
124
DELISTED
Athersys, Inc. Common Stock
ATHX
| $256K | 0.17% |
+7,112
| New | +$293K |
2021 Q2
0 quarters
|
|
125
Power Integrations
POWI
$2.51B
| $236K | 0.16% |
2,880
-3,446
| -54% | -$278K |
2020 Q4
2 quarters
|
|
Similar funds
BM
LFWA
RLWM
ACM
BSTWA
NI
TWPM
AA
Green Alpha Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Green Alpha Advisors held 140 positions worth $147M, up 45% from $101M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Green Alpha Advisors deployed $35.4M of net new capital in Q2 2021, opening 29 new positions and adding to 66 existing holdings. Its largest new stake was ASML: 2,173 shares worth $1.5M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, down from 58% a quarter earlier, followed by Healthcare and Real Estate.
On the sell side, the largest reduction was Tesla, an estimated $1.95M trimmed.
- Green Alpha Advisors's largest Q2 2021 buy was ASML: 2,173 shares worth $1.5M.
- Green Alpha Advisors added most to Hudson Pacific Properties in Q2 2021, an estimated $1.72M increase.
- Green Alpha Advisors's biggest Q2 2021 reduction was Tesla, cutting an estimated $1.95M.
- Green Alpha Advisors fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $1.4M.
- Green Alpha Advisors's ten largest holdings make up 16% of its $147M portfolio in Q2 2021.
- Green Alpha Advisors opened 29 new positions and closed 13 in Q2 2021.
- Green Alpha Advisors's portfolio value rose 45% quarter-over-quarter to $147M.
Based on Green Alpha Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.